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&- and a-subunits of GABAA receptors purified from the brains of 5-lo-day-old rats were investigated in the intact or completely N-deglycosylated 
state using the /I-subunit-specific monoclonal antibody bd-17 and polyclonal antibodies directed against synthetic amino acid sequences specific 
for the GABAA receptor/r,- or &subunits. The present results seem to indicate the existence of two different isoforms of the a-subunit and several 
different isoforms of the &-subunit of the GABA, receptor which probably are produced by alternative splicing. 
GABAA receptor; N-Deglycosylation: B-Subunit; Antibody 
1. INTRODUCTION 
The y-aminobutyric acid(A) (GABA.4) receptor is a 
ligand-gated ion channel and the major inhibitory 
neurotransmitter receptor in the vertebrate brain. 
Molecular biological studies have demonstrated the ex- 
istence of a variety of different receptor subunits, each 
encoded by a single gene [l]. Thus, so far 6~, 4fl-, 2y-, 
and lb-subunit of the GABAA receptor have been clon- 
ed and sequenced, and expression studies have in- 
dicated that at least three different subunits (cr, p and y) 
are necessary to reproducibly reconstitute GABA 
receptors with correct pharmacology [2]. These studies 
were supported by biochemical studies indicating the 
existence of several different a-subunit proteins of the 
GABAA receptor [3], some of which recently have been 
identified using polyclonal antibodies selectively 
recognizing individual a-subunits [4,5]. In a subsequent 
study, the existence of several different P-subunit pro- 
teins with apparent molecular weights between 50 and 
60 kDa was demonstrated [6]. Each of these proteins 
was photolabeled by the GABA* agonist [3H]muscimol 
and recognized by the monoclonal antibody bd-17, 
which has been demonstrated to selectively recognize 
the /Jz- and fl3-subunit of the GABAA receptor [7]. In- 
terestingly, however, the published amino acid se- 
quences indicated that the PI-, fl2- and Pj-subunits of 
the GABAA receptors consist of 449,450 and 448 amino 
acid residues respectively, and thus should exhibit a 
quite similar molecular weight of about 52 kDa [8]. In 
the present study, the apparent molecular weight of P- 
subunits of the GABA.A receptor was investigated 
before or after exhaustive N-deglycosylation using the 
P-subunit-selective monoclonal antibody bd-17 and 
polyclonal antibodies directed against specific amino 
acid sequences of the Pz- or ,&-subunit. 
2. MATERIALS AND METHODS 
The GABA \ receptor was extracted from the brains of 5-10 day- 
old-rats and purified by affinity chromatography on Affigel 15 (Bio- 
Rad. CA, USA) coupled to Ro 7-1986 as described previously 161. In 
the purified receptor preparation the GABAt-ben7odiazepine recep- 
tors were enriched ar least lOOO-fold compared to the original mem- 
brane fractions. 
For N-deglycosylalion purified receptor preparations (about 25 pg 
protein in 170 pl of a solution containing 0.4 M Tris-HCI, pH 8.6, 
0.5’% SDS and 50 mMb-mercaptoethanol) was denatured at 65°C for 
IO min. After cooling to room temperature several additions were 
made resulting in 500 pl of a solution containing 25 fig receptor pro- 
tein, 0.13 M Tris-HCI, pH 8.6, 0.17% SDS, 17 mM p- 
mercaptoethanol, 1.25% Nonidet P-40, 0.1 @,%‘I aprotinin, 1 FM 
leupeptin, 1 mM phenylmethylsulfonylfluoride (PMSF) and 10 mM 
EDTA. This solution was incubated with 3.7 U recombinant N- 
Glycanase (Genzyme, Boston, MA, USA) for 20 h at 37°C. After 
deglycosylation, receptor proteins were precipitated with 
methanol/chloroform [9], were then resuspended in a solution con- 
taining 2% SDS, 62.5 mM Tris-HCI, pH 6.8, 5% mercaproethanol, 
1 rnM EDTA and 10% glycerol and subjected to SDS-PAGE and 
Western blot analysis as described previously [6]. 
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Peptides /?l (191-197) (sequence YKLITKK), 82 (382-389) (se- 
quence AGLPRHSF) or p, (190-197) (sequence EHRLVSRN) were 
custom synthesized (Multiple Peptide Systems, San Diego, CA, USA) 
with an additional C-terminal cysteine each. Peptides were coupled to 
keyhole limpet haemocyanine (KLH) via the C-terminal cysteine [lo] 
and peptide KLH-conjugates (100 yg protein) emulsified with 
Freund’s complete adjutant were injected at rhree sites subcutaneous- 
ly into rabbits. Subsequent immunizations were in Freund’s in- 
complete adjutant at 3 week intervals. Animals were bled one and two 
\\eeks after the 41h and all subsequent immunizations. All rabbits im- 
munized produced antibodies recognizing the corresponding peptide 
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o,- (;ABA, receptors as measured by an ELlSA uting the pcpridei ot 
purified GABA, receptor a\ the antigen [j]. 
Anti-peptidc ,i’: (191-197), anti-pcptlde 3~ (182-389) and anti- 
peptidedq (IYO-197) antibodk were isolated from the wra of the rab 
bits by affinit) chromatography on thioprop~l-Sepharc,ie hB (Phar- 
macia, Fine Chemical\, 1983) coupled to the cysteinc residue of the 
re\pecti\e peptide,. 
For immunoprecipiration aliquors of the purit’led receptor prepaw 
tions \\erc incubated in the preiencc of antibody at 3°C o\ernipht. 
After addition of Immunoprecipirin (Bethesda Rccearch Labow 
torie\, XII>. USA) and \haklng for an additional 3 h al 4 <‘. the 
pt-ecipitate ~a) \\aihed three time) wilh buffet, 2nd the anlOllllt Of 
precipitated receptor \~a\ measured by a [‘HIflunitr~t/epam binding 
a\Sty [I I I. 
3. RESULTS AND DISCUSSlON 
GABA X receptors purified by affinity chromato- 
graphy from the brains of 5-IO-day-old rats were sub- 
jected to SDS-PAGE. The proteins were then transfer- 
red to nitrocellulose and probed with the monoclonal 
antibody bd-17. This antibody has been demonstrated 
to specifically recognize the PI- and fll-subunits of the 
GABA,, receptors [7]. In agreement with previous 
results [6], bd-17 labeled at least 4 different proteins in 
the apparent molecular weight range between 50 und 60 
kDa and a protein smear between 40 and 47 kDa 
(Fig. 1). Since the published amino acid sequences of 
the ,Yl- and /?l-subunit indicated that these subunits in 
the deglycosylated state should exhibit a rather similar 
apparent molecular weight [8], one possible explanation 
for the existence of a variety of different proteins iden- 
tified by bd-17 was the existence of$2- and $j-subunits 
in several different states of glycosylation. Complete 
deglycosylation of these subunits should then result in a 
single protein band identified by the antibody bd-17. 
GABAa receptors purified from the brains of 5-lo-day- 
old rats were therefore exhaustively treated with N- 
Glycanase. This enLyme (peptide: N-glycosidase F) 
hydrolyzes all classes of N-linked oligosaccharides at 
the asparaginyl residue and results in completely N- 
deglycosylated proteins [ 121. GABA., receptors were 
then again subjected to SDS-PAGE and Western blot 
analysis. As shown in Fig. 1, the monoclonal antibody 
bd-17 after complete N-deglycosylation of the purified 
GABA, receptor still recognized a variety of different 
proteins. Thus, two proteins with apparent molecular 
weights 51 and 53 kDa were strongly and at least three 
other proteins with apparent molecular weight 42, 44 
and 46 kDa were weakly labeled. The same pattern of 
labeling by bd-17 was observed whether purified 
GABA,‘, receptors were incubated with either half or 
twice the concentration of N-glycanase or tvhether 
receptors were incubated with /V-glycanase for 20 or 72 
h. Furthermore, a second and third addition of fresh N- 
Glycanase 19 and 48 h after the first addition, and in- 
cubation for an additional 24 h (resulting in a total of 
72 h of incubation with increasing concentrations of N- 
Glycanase) did not result in an immunolabeling pattern 
28 
N-Glycanase - - - - 
- Origin 
different from that iho\\n in Fig. 1. These results argue 
in favour of a complete Ndeglycosyiation of the 
GABA, receptor proteins and confirm the absence of a 
significant proteolytic action of’ the Mglycanase 
preparation under the conditions used. Since isolation 
and purification of GABA \ receptors \vas performed in 
the presence of a variety of protease inhibitors and the 
same pattern of labeling by the monoclonal antibody 
bd-17 was observed Lvhether GABA A-receptors fresh15 
purified by affinity chromatography at 4°C or rccep- 
tors incubated for 20 h at 37°C in the absence of N- 
glycanase were investigated (experiments not shown), 
the production by proteolytic degradation of d?- or 
dl-subunits of some of the protein bands identified by 
bd- 17 in receptor preparations before N-glycanase 
treatment is also rather unlikely (additional arguments 
see below) although it cannot completely be excluded. 
In order to identify the Jr- or di-subunit of the 
GABA receptor, polyclonal antibodies were raised 
against specific amino acid sequences of these subunits 
and purified from the sera of rabbits by affinity 
chromatography. These antibodies, anti-peptide d1 
(191-197), anti-peptide $1 (382-389) or anti-peptide ,j3 
(190-197), specifically recognized their immunizing 
peptide and purified GABA 4 receptors as demonstrated 
by ELlSA’s using the peptides or purified receptors as 
Volume 257, number I ,2 FEBS LETTERS August 1991 
antigens, and were able to precipitate 7.270, 12% or 
17% of the GABAA receptor present in the incubation, 
respectively. As shown in Fig. 1, anti-peptide ,L?Z 
(191-197) and anti-peptide p3 (190- 197) each 
predominantly identified a single protein band with ap- 
parent molecular weight 56 kDa in GABAA receptors 
purified from 5-lo-day-old rats. The apparent 
molecular weight of this protein band was identical to 
that of a protein band predominantly identified by the 
~-subunit-specific monoclonal antibody bd-17. These 
data indicate that BL- and ,@s-subunits exhibit an iden- 
tical apparent molecular weight of 56 kDa, a result ex- 
pected if oligosaccharide chains of similar apparent 
molecular weight are assumed to be associated with 
these subunits. After exhaustive N-deglycosylation, 
however, the anti-peptide,& (191-197) and anti-peptide 
,L?3 (190- 197) antibody each identified the same two pro- 
tein bands with apparent molecular weights of 51 and 
53 kDa which also were most prominently labeled by 
bd- 17. The apparent molecular weight of these proteins 
fit quite well compared to the theoretical molecular 
weight of about 52 kDa derived from the amino acid se- 
quences of both the ,IC?‘Z- or ~~-subunit f8], indicating a 
complete deglycosylation of these proteins. This con- 
clusion is further supported by a previous report [ 131 in- 
dicating that similar apparent molecular weights for p- 
subunits were obtained whether purified GABA., recep- 
tors were treated with endoglycosidase F, which similar 
to N-Glycanase removes N-linked carbohydrates from 
glycoproteins or with trifluoromethane sulfonic acid, 
which removes N-linked as well as O-linked car- 
bohydrate groups from glycoproteins. Thus, these data 
seem to indicate that at least two Pz- and two @J-subunit 
proteins with slightly different apparent molecular 
weight exist. In the intact GABAL\ receptor these pro- 
teins presumably are N-glycosylated to a different 
degree and thus exhibit a rather similar apparent 
molecular weight. An alternative explanation of a 
cross-reactivity of the antibodies with a different 
GABA receptor subunit or a protein not associated 
with the GABAh receptor but present in the purified 
receptor preparations is highly unlikely because it then 
has to be assumed that 3 different antibodies, each 
directed against a different epitope present on the Pz- 
and/or ~~-subunit crossreacted with the same protein. 
In order to further verify the identity of the @r-sub- 
unit of the GABAA receptor, a &~-subunit-specific an- 
tibody directed against a different epitope of the 
,#z-subunit than the anti-peptide fi2 (191-197) antibody 
was used. As shown in Fig. 1, surprisingly this an- 
tibody, anti-peptide P2 (382-389), only weakly labeled 
the protein band with apparent molecular weight 56 
kDa which was labeled predominantly by bd-17, anti- 
peptide p2 (191-197) or anti-peptide ,133 (190-197). In 
contrast, this antibody predominantly labeled at least 4 
different protein bands with apparent molecular 
weights 45, 47, 51 and 53 kDa. These protein bands 
seem to consist of P-subunits since protein bands with 
identical apparent molecular weights were labeled by 
the P-subunit-specific monoclonal antibody bd-17. 
After exhaustive N-deglycosylation, the anti-peptide ,1?2 
(382-389) antibody predominantly labeled 3 different 
protein bands with apparent molecular weights 42, 44 
and 46 kDa. Again protein bands with identical ap- 
parent molecular weights were labeled by the P-subunit 
specific monoclonal antibody bd-17. These proteins 
cannot have been produced by a proteolytic digestion of 
the ,/32-subunits identified by the anti-peptide & 
(191-197) antibodies, since loss by proteolytic digestion 
of the epitope identified by the anti-peptide PZ 
(191-197) antibody which is localized close to the mid- 
dle of the amino acid sequence of the @l-subunit [S] 
would have reduced the apparent molecular weights of 
the fi2-subunits much more dramatically than shown in 
Fig, 1. Furthermore, in this case the anti-peptide p2 
(382-389) antibody should then be able to strongly 
recognize the protein with apparent molecular weight 
56 kDa, identified by the anti-peptide flz 1191-197) an- 
tibody. Thus, the fact that two different antibodies 
directed against two different epitopes of the same 
flz-subunit predominantly recognize different proteins 
in purified GABAA receptors can only be explained by 
the assumption that these epitopes are not associated 
together in the same protein. This however is in ap- 
parent contradiction to the published amino acid se- 
quence of the PI-subunit [8] which indicates the ex- 
istence of both epitopes together in the same molecule. 
A possible resolution of this discrepancy is indicated in 
Fig. 1. In the intact as well as in the IV-deglycosylated 
GABA,\ receptor, the anti-peptide /?2 (191-197) an- 
tibody in addition to the strongly recognized protein 
bands seems to weakly identify the proteins recognized 
by the anti-peptide fi2 (382-389) antibody. Similarly, 
the anti-peptide ,I?Z (382-389) antibody weakly rec- 
ognizes the proteins identified by the anti-peptide ,L?‘z 
(191-197) antibody. It is thus possible that in a signifi- 
cant part of the @l-subunits both the epitopes compris- 
ing the amino acids 191-197 and the amino acids 
382-389 are coexisting. In addition, there have to exist, 
however, @l-subunits in which either the amino acids 
191-197 or the amino acids 382-389 are absent. Fur- 
thermore, there have to be ~2-subuIlits lacking other 
parts of the published amino acid sequence. Only then 
could the existence of several proteins strongly 
recognized by bd-17 or the anti-peptide,& (382-389) an- 
tibody be explained. Alternatively, these lower 
molecular weight proteins could be degradation prod- 
ucts of a ,&2-subunit which doesn’t contain the amino 
acids 191-197. This, however, is not very probable 
since, as shown in Fig. 1, these proteins are weakly 
identified by the anti-peptide, (191-197) antibody and 
as mentioned above, a series of protease inhibitors was 
used throughout the isolation and purification of the 
receptor and the ~-deglycosylation experiments. And 
29 
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finally since, for instance, the proteins identified by the 
anti-peptide @2 (191-197) or the anti-peptide $3 
(190-197) antibodies did not show such a significant 
heterogeneity. AI1 these results, however, could be ex- 
plained by the possibility that the expression of several 
parts of the ,5$subunit, amongst them parts containing 
the amino acids 191-197 or 382-389, is regulated by 
alternative splicing. Recently, two different isoforms of 
yz- [ 14,151 or &-subunit [16] messenger RNAs have 
been identified which are produced by alternative spiic- 
ing. The present results are in agreement with these 
reports and indicate that possibly a variety of 
Pz-subunit isoforms exist differing only in a small part 
of their molecules. The unequivocal identification of 
these GABAh receptor isoforms, the investigation of 
their regional and cellular distribution, the regulation 
of their expression and the investigation of their func- 
tion is a big challenge for the future of GABA receptor 
research. 
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